BSEOthers31 Jul 2026 · 31 Jul 2026, 02:42 pm

Please find attached the outcome of board meeting held on 31st July, 2026.

Cresanto Global Ltd · 531207

✦ AI SummaryRelated Party

Cresanto Global Ltd has announced the outcome of its board meeting held on July 31, 2026, where it considered and approved material related party transactions with its promoters and non-executive directors, Urmila Hansraj Sharma, Hitesh Bajoria, Nishant Nathmal Bajaj, and Prashant Nathmal Bajaj.

Analysis Scores

Earnings Impact1/10
Growth Catalyst1/10
Governance Concern6/10
Regulatory Risk2/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Cresanto Global Ltd - 531207 - Board Meeting Outcome for Meeting Held Today July 31, 2026

Attachments (1)

📄

8128706a-2c5e-4f86-ae0c-e3dffe5dece5.pdf

pdf

Download →
View document text
CRESANTO GLOBAL LIMITED (Formerly known as Raymed Labs Limited) CIN: L22203UP1992PLC014240 Corporate Office: 201, 2nd Floor, A wing, Corporate Avenue, Sonawale Lane, Goregaon East, Mumbai, Maharashtra 400063 Reg.off. -C- 273, C block, sector 63, Gautam Buddha Nagar, Noida, Uttar Pradesh, India, 201301, Website- www.cresantoglobal.com Email- raymedlabs@rediffmail.com, Phone no. 7738669898 BSE Limited, Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai - 400 001. Scrip code: 531207 Subject: Outcome of Board Meeting Ref: Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Dear Sir/Madam, Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("Listing Regulations"), we wish to inform you that the Board of Directors of the Company at its meeting held today i.e., 31st July, 2026, has inter alia considered and approved the following matters: 1. Material Related Party Transaction(s) under section 188 of the Companies Act, 2013 and Regulation 23 of SEBI (LODR) Regulations, 2015. Disclosure of information pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, read with SEBI Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated 11th November, 2024 are attached as “Annexure-A”. The meeting commenced at 02:15 p.m. and concluded at 02:30 p.m. Kindly take the same on record. CRESANTO GLOBAL LIMITED (Formerly known as Raymed Labs Limited) CIN: L22203UP1992PLC014240 Corporate Office: 201, 2nd Floor, A wing, Corporate Avenue, Sonawale Lane, Goregaon East, Mumbai, Maharashtra 400063 Reg.off. -C- 273, C block, sector 63, Gautam Buddha Nagar, Noida, Uttar Pradesh, India, 201301, Website- www.cresantoglobal.com Email- raymedlabs@rediffmail.com, Phone no. 7738669898 For Cresanto Global Limited (Formerly known as Raymed Labs Limited) (Prashant Nathmal Bajaj) Managing Director DIN: 06634046 Date: 31st July, 2026 Place: Mumbai CRESANTO GLOBAL LIMITED (Formerly known as Raymed Labs Limited) CIN: L22203UP1992PLC014240 Corporate Office: 201, 2nd Floor, A wing, Corporate Avenue, Sonawale Lane, Goregaon East, Mumbai, Maharashtra 400063 Reg.off. -C- 273, C block, sector 63, Gautam Buddha Nagar, Noida, Uttar Pradesh, India, 201301, Website- www.cresantoglobal.com Email- raymedlabs@rediffmail.com, Phone no. 7738669898 “Annexure-A” Disclosure of information pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, read with SEBI Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated 11th November, 2024 Sr. Particulars Information 1. Name of the related party 1. Urmila Hansraj Sharma (Promoter & Non- Executive Director) 2. Hitesh Bajoria (Promoter & Non-Executive Director) 3. Nishant Nathmal Bajaj (Promoter & Non- Executive Director) 4. Prashant Nathmal Bajaj (Promoter & Managing Director) 2. Nature of relationship [including nature The above related parties have significance of its interest (financial or otherwise)] influence over the reporting entity and falls under the related party under Section 2(76) of the Act and Regulation 2(1)(zb) of the SEBI Listing Regulations. 3. Type of the proposed transaction The Company proposes to enter into such Transaction(s)/ contract(s)/ Arrangement(s)/ Agreement(s)/ loan transaction(s)/ to extend or avail the corporate guarantee in lieu of loan taken and such other business transaction(s) as and when required by and inter-se. 4. Nature, duration/tenure, material terms, Transactions in the normal course of business CRESANTO GLOBAL LIMITED (Formerly known as Raymed Labs Limited) CIN: L22203UP1992PLC014240 Corporate Office: 201, 2nd Floor, A wing, Corporate Avenue, Sonawale Lane, Goregaon East, Mumbai, Maharashtra 400063 Reg.off. -C- 273, C block, sector 63, Gautam Buddha Nagar, Noida, Uttar Pradesh, India, 201301, Website- www.cresantoglobal.com Email- raymedlabs@rediffmail.com, Phone no. 7738669898 monetary value and particulars of with terms and conditions that are generally contract/ arrangement prevalent in the industry segments that the company is operating in. Monetary value of transactions subject to a maximum as below through contracts/arrangements for a period from conclusion of the AGM held in the FY 26-27 to till the AGM to be held in the FY 27-28. 5. Particulars of the proposed transaction Same as point 3 above. 6. Tenure of the transaction Conclusion of the AGM held in the FY 26-27 to till the AGM to be held in the FY 27-28. 7. Value of the proposed transaction 1. Urmila Hansraj Sharma (Promoter & Non- Executive Director) – Rs. 5 crores 2. Hitesh Bajoria (Promoter & Non-Executive Director) - Rs. 5 crores 3. Nishant Nathmal Bajaj (Promoter & Non- Executive Director) - Rs. 5 crores 4. Prashant Nathmal Bajaj (Promoter & Managing Director) - Rs. 5 crores